An evidence-based review of natalizumab therapy in the management of Crohn’s disease

Por Edula, Raja GR, Picco, Michael F
Publicado em 2009

Targeting Mucosal Healing in Crohn’s Disease

Por Picco, Michael F., Farraye, Francis A.
Publicado no Gastroenterol Hepatol (N Y) (2019)

The use of chromoendoscopy for surveillance of inflammatory bowel disease

Por Lichtenstein, Gary R., Picco, Michael F., Solomon, Sanjeev, Bickston, Stephen J.
Publicado no VideoGIE (2018)

Association between inflammatory bowel disease and chronic obstructive pulmonary disease: a systematic review and meta-analysis

Por Labarca, Gonzalo, Drake, Lauren, Horta, Gloria, Jantz, Michael A., Mehta, Hiren J., Fernandez-Bussy, Sebastian, Folch, Erik, Majid, Adnan, Picco, Michael
Publicado no BMC Pulm Med (2019)

COVID-19 polymerase chain reaction testing before endoscopy: an economic analysis

Por Corral, Juan E., Hoogenboom, Sanne A., Kröner, Paul T., Vazquez-Roque, Maria I., Picco, Michael F., Farraye, Francis A., Wallace, Michael B.
Publicado no Gastrointest Endosc (2020)

Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel Disease

Por Wang, Ming-Hsi, Friton, Jessica J, Raffals, Laura E, Leighton, Jonathan A, Pasha, Shabana F, Picco, Michael F, Cushing, Kelly C, Monroe, Kelly, Nix, Billy D, Newberry, Rodney D, Faubion, William A
Publicado no J Crohns Colitis (2019)